Andrew H. Lane, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 80,000 shares at $92.00 ($7.4M) on 2020-05-05, disclosed to the SEC on 2020-05-07.
Open-market sale of $7.4M ABT by Executive Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ABT | SELL | 2019-06-14 | $12.0M | — | Filing → |
| ABT | SELL | 2018-08-31 | $1.2M | — | Filing → |